Bluejay Diagnostics, Inc.
General ticker "BJDX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $389.2K (TTM average)
Bluejay Diagnostics, Inc. does not follow the US Stock Market performance with the rate: -22.4%.
Estimated limits based on current volatility of 5.7%: low 1.13$, high 1.27$
Factors to consider:
- Total employees count: 10 as of 2023
- Top business risk factors: Economic downturns and volatility, Inability to raise capital, Supply chain disruptions, Product development risks, License agreement risks
- Current price 26.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.62$, 9.77$]
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 3.83$]
Financial Metrics affecting the BJDX estimates:
- Positive: with PPE of -0.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -1083.14 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 86.06 > 63.39
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of -3.67 <= 0
- Negative: Investing cash flow per share per price, % of -42.49 <= -14.38
Short-term BJDX quotes
Long-term BJDX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.25MM | $0.00MM | $0.00MM |
| Operating Expenses | $9.57MM | $10.31MM | $7.17MM |
| Operating Income | $-9.32MM | $-10.31MM | $-7.17MM |
| Non-Operating Income | $0.02MM | $0.36MM | $-0.55MM |
| Interest Expense | $0.00MM | $0.00MM | $0.82MM |
| R&D Expense | $4.15MM | $5.71MM | $3.47MM |
| Income(Loss) | $-9.30MM | $-9.95MM | $-7.72MM |
| Profit(Loss)* | $-9.30MM | $-9.95MM | $-7.72MM |
| Stockholders Equity | $11.54MM | $2.89MM | $5.73MM |
| Assets | $13.52MM | $4.87MM | $6.66MM |
| Operating Cash Flow | $-7.74MM | $-8.31MM | $-7.82MM |
| Capital expenditure | $1.20MM | $0.70MM | $0.31MM |
| Investing Cash Flow | $-1.20MM | $-0.70MM | $-0.31MM |
| Financing Cash Flow | $0.01MM | $1.11MM | $10.22MM |
| Earnings Per Share** | $-73.77 | $-72.62 | $-42.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.